Quantcast
Last updated on April 19, 2014 at 7:50 EDT

Latest Fred D. Lublin Stories

2014-02-10 08:25:28

ROCKVILLE, Md., Feb. 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infectious and other diseases, announced today that Rhonda Voskuhl, M.D., the lead investigator of the Phase II clinical trial evaluating the Company's oral estriol product candidate, Trimesta(TM), for the treatment of relapsing-remitting multiple sclerosis (MS), will present topline results at the American...

2013-11-21 23:20:17

Reportbuyer.com just published a new market research report: Multiple Sclerosis: KOL Insight. London (PRWEB) November 21, 2013 The multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen’s Tecfidera (dimethyl fumarate) has revolutionised multiple sclerosis treatment in the US, eroding significant market share from older therapies. However, patent concerns has stalled Tecfidera’s launch in Europe. Genzyme have taken advantage of this delay with...

2013-07-27 23:01:01

SclerosisTreatment.com reviews a new revolutionary natural multiple sclerosis treatment. The new treatment promoted by Dr. Gary M. Levin in his Natural Multiple Sclerosis Treatment Book is considered to be a medical breakthrough in the field of sclerosis treatment. Denver, Colorado (PRWEB) July 27, 2013 http://www.SclerosisTreatment.com reveals that Dr. Gary M. Levin is a retired surgeon who dedicated more than 30 years to medical research. He tested several alternative treatments and...

2013-05-24 08:22:40

On World MS Day, May 29, People from MS Societies in Over 40 Countries Around the World are joining together to raise Awareness and Unite in the MS Movement Young people with MS are taking the lead and sharing the mottos that guide their lives NEW YORK, May 24, 2013 /PRNewswire-USNewswire/ -- Multiple sclerosis is a life altering disease that affects each person in a unique and different way. More than 2.1 million people worldwide live with MS, which is why demonstrating the...

2013-05-10 23:01:00

Dr. Gary M. Levin´s Multiple Sclerosis Natural Treatment and new MS Research was recently endorsed by the Daily Gossip Magazine via a recent review and price analysis. Denver, Colorado (PRWEB) May 10, 2013 According to http://www.SclerosisTreatment.com researchers are looking at MS every conceivable way taught by medicine, and although the FDA has approved several drug-based treatments, there isn´t a permanent cure for the condition. The Multiple Sclerosis Treatment by Dr. Gary...

2013-04-16 08:28:33

-- 65 new grants and fellowships part of 2013 investment of over $47 million in cutting-edge research projects moving us closer to a world free of MS NEW YORK, April 16, 2013 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed another $18 million to support up to 65 new MS research projects. These new awards are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever. (Logo:...

2013-04-05 08:23:02

People living with multiple sclerosis (MS) and MS experts available to speak about the importance of NIH funding for life-changing MS research WASHINGTON, April 5, 2013 /PRNewswire-USNewswire/ -- On April 8 at 11 a.m., thousands of people will gather on the Carnegie Library grounds to participate in the Rally for Medical Research to raise awareness of the critical need to make funding for the National Institutes of Health (NIH) a priority. The National MS Society and nearly 200 other...

2013-02-26 12:27:04

Leading Research Center for Multiple Sclerosis Takes Name of Benefactors NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- The Board of Directors of the Multiple Sclerosis Research Center of New York (MSRCNY) today announced the re-naming of the institution as the Tisch MS Research Center of New York. Representing a new model of healthcare, the research center, coupled with its clinical affiliate, the International Multiple Sclerosis Management Practice (IMSMP), is the largest MS...

2013-02-17 23:01:36

Ironclad Integrity Ltd. announces Dr. Gary M. Levin´s natural Multiple Sclerosis treatment as an alternative therapy that delivers effective results. Denver, CO (PRWEB) February 17, 2013 Health experts know very little about the causes of Multiple Sclerosis. Risk factors are still not accurately highlighted and medicine such as antidepressants, interferons, mioxantrone and steroids features side-effects that many MS patients don´t feel are worth in the long run. According to...

2012-12-06 16:23:59

The partners work together to accelerate development of new treatments for multiple sclerosis NEW YORK, CLEVELAND and TUCSON, Ariz., Dec. 6, 2012 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society and Critical Path Institute (C-Path) announced today that they have joined forces to launch the Multiple Sclerosis Outcome Assessments Consortium (MSOAC). This coalition of industry, academia, patient representatives, regulatory agencies, and the National MS Society will...